Hydroxyapatite deposition disease of the joint.
Basic calcium phosphate (BCP) crystals include partially carbonate-substituted hydroxyapatite, octacalcium phosphate, and tricalcium phosphate. They may form deposits, which are frequently asymptomatic but may give rise to a number of clinical syndromes including calcific periarthritis, Milwaukee shoulder syndrome, and osteoarthritis, in and around joints. Recent data suggest that magnesium whitlockite, another form of BCP, may play a pathologic role in arthritis. Data from the past year have provided further understanding of the mechanisms by which BCP crystals induce inflammation and degeneration. There remains no specific treatment to modify the effects of BCP crystals. Although potential drugs are being identified as the complex pathophysiology of BCP crystals is unraveled, much work remains to be done in order to translate research advances to date into tangible clinical benefits.
Department of Rheumatology, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland.
Eamonn S
ES
Molloy
Geraldine M
GM
McCarthy
D002128:Calcium Metabolism Disorders / Q000378:metabolism; D017886:Durapatite / Q000378:metabolism*; D006801:Humans; D007596:Joints / Q000378:metabolism*; D010003:Osteoarthritis / Q000378:metabolism*
D017886:Durapatite